VoxNeuro raises $4.5 million CAD to scale brain performance software across U.S. clinics

VoxNeuro, which develops software that measures brain performance, has raised $4.5 million CAD in all-equity funding as the company looks to expand across the U.S. With this funding, VoxNeuro plans to accelerate its product development and operational model as it scales clinical installations across the U.S.

 VoxNeuro is an alumnus of HealthMINT™ program and presented at the OBIO® Investment Summit.